In recent years, there has been an increasing interest in determining the related pathogenic mechanisms of ROP [16] and related biomarkers such as apelin-13 and VEGF, but there is insufficient conclusive evidence to support their usefulness; our research results provide some evidence. The gene discussed is APLN; the disease is retinopathy of prematurity.